Approval · Notice of Compliance 23996 · 2020
FIRDAPSE: Notice of Compliance 23996
Issued July 31, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23996
- Date
- July 31, 2020
- Company
- Catalyst Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRDAPSE | 02502984 | Marketed |
Medicinal ingredients
- AMIFAMPRIDINE (SUPPLIED AS AMIFAMPRIDINE PHOSPHATE) 10 MG per TAB